Search - tctmd.com

Displaying 781 - 800 of 1574

Sort: Relevancy | Date

News Opinion Off Script TCT 2018

Off Script: Sharing, Caring, and Daring to Dream

Kwan S. Lee

September 22, 2018

Presentation TCT 2018

ReCre8: Summary and Clinical Implications

Presenter: Sripal Bangalore, Lawrence A. Garcia, Pieter R. Stella

September 22, 2018

News Conference News TCT 2018

TALENT: Indian-Made Supraflex DES Stands Up Well Against Xience in All-Comers

Todd Neale

September 22, 2018

Presentation TCT 2018

TALENT: Summary and Clinical Implications

Presenter: Sripal Bangalore, Lawrence A. Garcia, Patrick W. Serruys

September 22, 2018

Presentation TCT 2018

BIONYX: Summary and Clinical Implications

Presenter: Sripal Bangalore, Lawrence A. Garcia, Clemens von Birgelen

September 22, 2018

Polymer-Free BioFreedom Stent as Safe as Orsiro, but Not as Effective

News Conference News TCT 2018

CORRECTION: Polymer-Free BioFreedom Stent Faces Off Against Orsiro

Michael O'Riordan

September 22, 2018

Presentation TCT 2018

The Overview of Current Evidence of RDN: The Result of RADIANCE-HTN SOLO Trial and SPYRAL HTN-on MED Trial

Presenter: Kenneth J. Cavanaugh Jr, Takafumi Ueno, Justin E. Davies

September 22, 2018

News Conference News TCT 2018

ReCre8: Physician-Led Study Shows Noninferiority of Polymer-Free Stent Compared With Permanent-Polymer ZES at 1 Year

Yael L. Maxwell

September 22, 2018

Presentation TCT 2018

CMS Perspectives

Presenter: Lori M Ashby

September 22, 2018

Presentation TCT 2018

Clinician Perspectives

Presenter: Megan Coylewright

September 22, 2018

Presentation TCT 2018

Patient-Centered Engagement in Trials: Case Example - ADAPTABLE

Presenter: John C Laschinger, J. Dawn Abbott, Lori M Ashby, Robert A. Byrne, David A. Cox, Mona Fiuzat, Christopher O'Connor, John A. Spertus, Susan Strong

September 22, 2018

Presentation TCT 2018

FDAs Patient Engagement Initiatives: How FDA Can Incorporate Patient Centered and Patient Reported Outcomes in Regulatory Decision-Making

Presenter: John C Laschinger

September 22, 2018

Presentation TCT 2018

The Current Target Population for LAAC Closure Based on the Results of Clinical Trials in Europe

Presenter: Marek Grygier

September 22, 2018

Presentation TCT 2018

The Overview of Clinical Trials and Current Target Population for LAAC Closure

Presenter: Shephal Doshi

September 22, 2018

Presentation TCT 2018

How the Best-CLI Trial Will Change Clinical Practice

Presenter: Ehrin J. Armstrong, Sahil A. Parikh, Matthew T. Menard

September 22, 2018

Presentation TCT 2018

Clinical Trials for Short DAPT: FDA Perspective

Presenter: Christopher J Popma

September 22, 2018

News Opinion Editor's Corner TCT 2018

TCT 2018, Day One: ‘Back to the Future’ With Stents, Stents, and More Stents

Shelley Wood

September 22, 2018

Presentation TCT 2018

Status Update of the TAVR UNLOAD Trial Moderate AS Patients with Reduced Ejection Fraction and Heart Failure

Presenter: Allan Schwartz, Stephan Windecker, Joost Daemen

September 22, 2018

Presentation TCT 2018

Rationale for Treating SASS and Update of the EARLY-TAVR Trial

Presenter: Allan Schwartz

September 22, 2018

Presentation TCT 2018

The Case for TAVR in Low-Risk Patients: Rationale, Current Data, Clinical Trends, and Updates from the Ongoing Clinical Trials

Presenter: Allan Schwartz, Stephan Windecker, Jeffrey J. Popma

September 22, 2018

Advertisement

Off Script: Sharing, Caring, and Daring to Dream

ReCre8: Summary and Clinical Implications

TALENT: Indian-Made Supraflex DES Stands Up Well Against Xience in All-Comers

TALENT: Summary and Clinical Implications

BIONYX: Summary and Clinical Implications

CORRECTION: Polymer-Free BioFreedom Stent Faces Off Against Orsiro

The Overview of Current Evidence of RDN: The Result of RADIANCE-HTN SOLO Trial and SPYRAL HTN-on MED Trial

ReCre8: Physician-Led Study Shows Noninferiority of Polymer-Free Stent Compared With Permanent-Polymer ZES at 1 Year

CMS Perspectives

Clinician Perspectives

Patient-Centered Engagement in Trials: Case Example - ADAPTABLE

FDAs Patient Engagement Initiatives: How FDA Can Incorporate Patient Centered and Patient Reported Outcomes in Regulatory Decision-Making

The Current Target Population for LAAC Closure Based on the Results of Clinical Trials in Europe

The Overview of Clinical Trials and Current Target Population for LAAC Closure

How the Best-CLI Trial Will Change Clinical Practice

Clinical Trials for Short DAPT: FDA Perspective

TCT 2018, Day One: ‘Back to the Future’ With Stents, Stents, and More Stents

Status Update of the TAVR UNLOAD Trial Moderate AS Patients with Reduced Ejection Fraction and Heart Failure

Rationale for Treating SASS and Update of the EARLY-TAVR Trial

The Case for TAVR in Low-Risk Patients: Rationale, Current Data, Clinical Trends, and Updates from the Ongoing Clinical Trials

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content